the evolving treatment landscape of scd
Published 2 years ago • 109 plays • Length 2:20Download video MP4
Download video MP3
Similar videos
-
3:15
how novel agents are transforming the treatment landscape of scd
-
0:45
current landscape of treatment for scd: an update from ash 2023
-
1:21
the current treatment landscape for scd
-
1:15
exploring the evolving treatment landscape of myelofibrosis
-
2:00
the current landscape of scd treatment
-
43:42
easl studio - s2 e17 - easl haemochromatosis guidelines 2022
-
3:51
sickle cell disease | moa animation
-
21:38
drawing the line: the rationale behind blood tube collection order
-
2:03
the current landscape of treatment for bpdcn
-
1:23
the current landscape of treatment for hr-mds: an update from ash 2023
-
3:36
the genetic landscape of mds: how this is improving & impacting the development of therapies
-
1:18
the epidemiology and treatment of chronic gvhd post-allosct
-
2:10
an update on the treatment of scd
-
4:08
current and future treatment of scd
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
2:16
correcting the function of mutated hemoglobin with gene therapy for scd
-
1:04
the current standard of care for mds-related cytopenias and how treatment strategies may evolve
-
1:25
how the role of transplant in all is evolving with the introduction of novel immunotherapies
-
5:25
how the aml treatment landscape is changing with the introduction of novel targeted agents
-
2:21
the role of melflufen in the myeloma treatment landscape
-
2:05
an insight into the role of the sickle cell society